- Home
- MDGL vs MNSO Comparison
MDGL vs MNSO Comparison
Compare MDGL & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- MNSO
- Stock Information
- Founded
- MDGL 2011
- MNSO 2013
- Country
- MDGL United States
- MNSO China
- Employees
- MDGL N/A
- MNSO N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- MNSO Department/Specialty Retail Stores
- Sector
- MDGL Health Care
- MNSO Consumer Discretionary
- Exchange
- MDGL Nasdaq
- MNSO Nasdaq
- Market Cap
- MDGL 6.1B
- MNSO 5.3B
- IPO Year
- MDGL N/A
- MNSO 2020
- Fundamental
- Price
- MDGL $301.00
- MNSO $17.99
- Analyst Decision
- MDGL Strong Buy
- MNSO Buy
- Analyst Count
- MDGL 9
- MNSO 4
- Target Price
- MDGL $420.63
- MNSO $24.40
- AVG Volume (30 Days)
- MDGL 282.9K
- MNSO 632.4K
- Earning Date
- MDGL 08-06-2025
- MNSO 08-29-2025
- Dividend Yield
- MDGL N/A
- MNSO 3.57%
- EPS Growth
- MDGL N/A
- MNSO 3.84
- EPS
- MDGL N/A
- MNSO 1.09
- Revenue
- MDGL $317,383,000.00
- MNSO $2,438,853,167.00
- Revenue This Year
- MDGL $286.17
- MNSO $25.91
- Revenue Next Year
- MDGL $64.17
- MNSO $18.77
- P/E Ratio
- MDGL N/A
- MNSO $17.03
- Revenue Growth
- MDGL N/A
- MNSO 21.15
- 52 Week Low
- MDGL $200.63
- MNSO $12.51
- 52 Week High
- MDGL $377.46
- MNSO $27.71
- Technical
- Relative Strength Index (RSI)
- MDGL 56.69
- MNSO 48.26
- Support Level
- MDGL $284.02
- MNSO $17.91
- Resistance Level
- MDGL $311.21
- MNSO $18.75
- Average True Range (ATR)
- MDGL 11.80
- MNSO 0.36
- MACD
- MDGL 0.92
- MNSO 0.06
- Stochastic Oscillator
- MDGL 66.29
- MNSO 55.98
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.